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Remote distal enhancers may be located tens or thou-
sands of kilobases away from their promoters. How they
control gene expression is still poorly understood. Here,
we analyze the influence of a remote enhancer on the
balance between repression (Polycomb—PcG) and acti-
vation (Trithorax—TrxG) of a developmentally regulated
gene associated with a CpG island. We reveal its essen-
tial, nonredundant role in clearing the PcG complex and
H3K27me3 from the CpG island. In the absence of the
enhancer, the H3K27me3 demethylase (JMJD3) is not
recruited to the CpG island. We propose a new role of
long-range regulatory elements in removing repressive
PcG complexes.
Supplemental material is available for this article.
Received May 9, 2011; revised version accepted July 5, 2011.
It is still not fully understood how genes are switched on
or off during differentiation and development. However,
the role of remote regulatory elements in this process is
thought to be critical (Bulger and Groudine 2011). One
important epigenetic mechanism regulating many genes
involves the opposing effects of the Polycomb (PcG, re-
pressive) and Trithorax group (TrxG, activating) proteins,
which play critical roles in stem cell biology, develop-
ment, and cancer (Simon and Kingston 2009). The pro-
moters of most PcG/TrxG target genes are associated
with CpG islands that remain unmethylated in all cell
types (Mendenhall et al. 2010; MD Lynch, AJ Smith,
M De Gobbi, M Flenley, JR Hughes, D Vernimmen,
H Ayyub, JA Sharpe, JA Sloane-Stanley, L Sutherland,
et al., in prep.). During lineage commitment and differ-
entiation, PcG complexes are cleared from silenced genes
and replaced by TrxG complexes as these genes are
switched on. Specific histone methyltransferases in these
complexes create characteristic chromatin signatures
when PcG (H3K27me3) or TrxG (H3K4me3) complexes
are bound to chromatin. Bivalent chromatin patterns
(H3K27me3 and H3K4me3) may be seen prior to com-
mitment, and these two chromatin marks are then re-
solved during differentiation (Sawarkar and Paro 2010;
Surface et al. 2010). Bivalent domains may also arise de
novo during differentiation (Roh et al. 2006; Mohn et al.
2008). The recruitment and removal of PcG and TrxG
complexes are a dynamic process. However, the potential
of remote cis-acting elements to influence the balance
between repression and activation throughout develop-
ment and differentiation has not been explored. To
address these issues, we characterized changes in the
recruitment of transcription factors (TFs), cofactors,
chromatin-associated proteins (including PcG and TrxG),
and associated chromatin modifications to the human
a-globinCpG island in the presence or absence of a distant
enhancer.
A major problem in analyzing these aspects of gene
regulation arises when perturbation of the gene in ques-
tion (e.g., a key TF) leads to a perturbation of cell fate. In
this case, the cellular phenotype alters as regulation of
the gene under investigation is altered. To circumvent
this, such experiments are often done in cell lines whose
fate is fixed. To analyze human a-globin expression in pri-
mary cells, we developed an experimental model in which
the human a-globin cluster (117 kb) replaces the mouse
a-globin cluster (87 kb; humanizedmodel) (Fig. 1; Wallace
et al. 2007). Since a-globin is an end product of a gene
regulatory network, perturbing this gene has no effect on
cell fate. Expression of the human a-globin genes is con-
trolled by remote upstream regulatory elements (MCSR1–4),
of which MCS-R2 (also known as HS-40) (Fig. 1), located
60 kb upstream of the a-globin promoters, is the major
enhancer element (Higgs et al. 2008). In the humanized
system in which MCS-R2 has been deleted by homolo-
gous recombination, the erythroid progenitors in adultmice
differentiate normally, and thus, in terms of the trans-acting
environment, the normal and mutant cells are directly
comparable (Vernimmen et al. 2009). Any differences are
solely due to the presence or absence of MCS-R2 in cis to
the promoter.
Here we show that, in erythroid cells, the remote
tissue-specific enhancer (MCS-R2) plays an essential, non-
redundant role in clearing the PcG complex and its
associated modification (H3K27me3) from the CpG is-
land, when the a-globin genes become fully activated.
Furthermore, in the absence of the enhancer, the CpG is-
land does not recruit the H3K27 demethylase JMJD3.
This demonstrates that in addition to the recruitment of
TFs, cofactors, and the preinitiation complex (PIC) at the
promoter, long-range regulatory elements also play a crit-
ical role in removing repressive PcG complexes.
Results and Discussion
Using the humanized mouse, we previously showed that
the removal of MCS-R2 dramatically reduces the forma-
tion of chromosomal looping, which normally occurs
between the upstream regulatory elements and the pro-
moter in erythroid cells. In the absence of MCS-R2, the
human a-globin genes are expressed at <2% of normal, in
erythroid cells (Vernimmen et al. 2009). Here, we first
determined the effect of MCS-R2 on recruitment of key,
cell type-specific, and ubiquitously expressed TFs known
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to bind the a-globin promoter in Ter119+ mature eryth-
roblasts (Vernimmen et al. 2007). In the absence of MCS-
R2, TFs (e.g., Sp-XKLF and NFY) and cofactors, such as
histone acetyl transferases (PCAF, GCN5, CBP, and p300),
are not recruited efficiently (Supplemental Table 1).
These findings are reflected by suboptimal histone acet-
ylation (Supplemental Table 1). Of interest, there is a
progressive decrease in TF occupancy at key cis elements
(MCS-R1/HS-48, MCS-R3/HS-33, and MCS-R4/HS-10)
along the chromosome, with the a-globin promoter being
the most affected (Supplemental Fig. 1; Supplemental
Table 1). Furthermore, in the absence of MCS-R2, ubiq-
uitination of H2B (H2Bub, associated with activation)
does not occur efficiently at the a-globin gene (Fig. 2, left
panel). Ubiquitination of H2B is thought to be required for
subsequent methylation of H3K79 by Dot1 (Shilatifard
2008), and without MCS-R2, H3K79 is not efficiently
methylated (Fig. 2; Supplemental Fig. 2). As previously
described (Vernimmen et al. 2007), without MCS-R2,
occupancies of the PIC components (TBP, TFIIE, andTFIIB)
were all low with an even more dramatic effect on PolII
(Fig. 2; Supplemental Fig. 1) compared with the normal
chromosome. These findings confirm that in the human-
ized mouse cells (as in primary human and mouse cells),
a key role of the upstream element (MCS-R2) is to
facilitate recruitment and/or stabiliza-
tion of the PIC at the a-globin pro-
moter, late during erythropoiesis.
We then evaluated the role of MCS-
R2 on the deposition of methyl groups
to the Lys 4 residue of histone H3. As in
human primary erythroblasts (De
Gobbi et al. 2007), the upstream ele-
ments are marked by mono- and di-
methyl H3K4 in fully active humanized
erythroid cells (Supplemental Fig. 3). In
contrast, the chromatin associated with
the a-globin promoter and the body of
the gene is modified by H3K4me3 (Fig.
2, right panel; Supplemental Fig. 3).
These findings are also consistent with
the chromatin features of enhancers
and promoters, as established in ge-
nome-wide analyses (Heintzman et al.
2007). In the absence of MCS-R2, the
mono- and dimethylation of H3K4
seem to occur normally (Supplemen-
tal Fig. 3, left panel). Moreover and
more unexpectedly, despite the absence
of detectable H2Bub and H3K79me3 and
the associated transcription (expression
of only;2% of normal), the overall level
of H3K4me3 at the a-globin gene was
;50% of that seen in the fully active,
highly transcribed gene (considering the
amount of H3K4me3 detected on the
endogenous control) (Fig. 2; Supplemen-
tal Fig. 3). Note that, in the absence of
MCS-R2, the distribution of mono-, di-,
and trimethyl H3K4 becomes skewed
more to the promoter than the body of
the gene. This might be partially due to
higher levels of H3 occupancy at the
promoter in the DMCS-R2 compared
with normal (Supplemental Fig. 4). Of
interest, in the absence of the enhancer, H3K36me3 (a
marker of transcriptional elongation) is also detectable
(Supplemental Fig. 5).
The H3K4me3 modification is imposed by the human
TrxG proteins, which include several complexes (hSet1
and MLL1-5) (Shilatifard 2008). It has recently been
shown that H3K4 methylation at CpG islands may be
mediated via the hSet1 complex, which contains a CpG
island-binding protein (CGBP, or Cfp1). CGBP is thought
to bind unmethylated CpG-rich sequences irrespective of
transcription, thereby recruiting hSet1 (Thomson et al.
2010). This implies that chromatin at unmethylated CpG
islands might be modified by H3K4me3 as a default state.
Here we found that in human nonerythroid cells, CGBP/
Cfp1 is not detectable at the associated CpG island (as
judged by two different antibodies) (Supplemental Fig. 6).
Similarly, when the a genes are severely down-regulated
in the humanized mouse MCS-R2 mutant, CGBP/Cfp1 is
present at very low levels (Fig. 2; Supplemental Fig. 7).
Thus, CGBP/Cfp1 is only readily detected in association
with high levels of a-globin expression. Therefore, it
seems unlikely that the relatively high levels of
H3K4me3 seen in the DMCS-R2 mutant (when the a
genes are expressed at relatively low levels) reflect a default
state mediated by CGBP/Cfp1. In contrast, it suggests
Figure 1. Generation of humanized mice as a model to study the human a-globin locus and
organization of the human a-globin cluster. A region of conserved synteny in mouse
chromosome 11 was replaced by the orthologous human region (Wallace et al. 2007). In this
study, heterozygous mice were used to avoid lethality using the MCS-R2 deletion (DMCS-R2)
but also to keep the other allele (mouse) as an endogenous positive control. The globin genes
are shown as labeled red boxes. The positions of previously described, DNaseI-hypersensitive
sites are shown as arrows. The widely expressed gene NPRL3 (also known as the 14 gene in
human or the Prox gene in mouse) transcribed from the opposite strand to that of the a-globin
is shown as an orange box. Short vertical lines (black) indicate amplicons used in ChIP
experiments. Gray boxes refer to previously defined multispecies conserved elements (MCS)
and light-green boxes indicate CpG islands.
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that H3K4me3 might be a sensitive mark of basal tran-
scription. Interestingly, it was previously suggested that
CpG islands marked by H3K27me3 may exclude binding
of CGBP (Thomson et al. 2010).We showed previously that
a functionally repressive PcG complex is bound at the
CpG islands associated with the human a-globin pro-
moters in human nonerythroid cells, in which the a genes
are transcriptionally silent (Garrick et al. 2008). Here, we
show that CGBP is indeed excluded from CpG islands
bound by PcG by comparing human nonexpressing (PcG-
bound) versus expressing (PcG-unbound) cells (Supple-
mental Fig. 6). We therefore next determined whether the
lack of CGBP recruitment in the DMCS-R2 mutant is
associated with persistent PcG binding.
PcG complex is normally bound to both the adult (a) and
embryonic (z) globin CpG islands in human embryonic
Figure 2. H3K4me3 is not associated with H2Bub, H3K79me3, Pol II, and CGBP. Real-time PCR analysis of immunoprecipitated chromatin
using the antibodies indicated in MCS-R2 (left) and +MCS-R2 (right) humanized erythroid cells (Ter119-positive cells purified by
automagnetic-activated cell sorting). The Y-axis represents enrichment over the input DNA, normalized to a control sequence in the mouse
GAPDH gene. The X-axis represents the positions of the TaqMan probes used. The coding sequence is represented by the three exons (Promoter/
Ex1, Ex2, Ex3) of the human a-globin genes as shown in Figure 1. (Mouse Ex1 and Mouse Ex2) Control sequences at the mouse a-globin gene;
(CpG Act) additional control sequence at the CpG island of the mouse b-actin gene. The amplicons highlighted in red represent deleted regions
in the humanized mice, for which no PCR signal is observed. Error bars correspond to 61 SD from at least two independent ChIPs. The CGBP
antibody used here was purchased from Abcam.
Long-range control of epigenetic regulation
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stem cells and pluripotent progenitors, in which expression
of the a genes is detectable at extremely low levels (De
Gobbi et al. 2011). Polycomb remains bound to the silenced
embryonic (z) gene in mature erythroid cells. In contrast,
PcG is cleared from the adjacent a-globinCpG island as this
gene becomes expressed at high levels in mature erythroid
cells (Garrick et al. 2008; DeGobbi et al. 2011). This pattern
is fully recapitulated in the humanized mouse system (Fig.
3, right panel; Supplemental Fig. 8). Moreover, we show
here that as the PRC2-associated chromatin modification
(H3K27me3) is erased, the histone H3K27 demethylase
JMJD3 is recruited (Fig. 3, right panel; Supplemental Fig. 8).
Figure 3. Removal of Polycomb repressor complexes is dependent on MCS-R2 and associated with recruitment of JMJD3. Graphs are displayed
as in Figure 2. Additional amplicons flanking the embryonic z-globin gene (142, 147, and 149) have been used in these experiments to highlight
the two independent PcG domains observed in the mutant human allele DMCS-R2 (shown in the left panel). The shaded area represents the
adult a-globin CpG island, from which PcG is normally cleared in the Normal allele in erythroid cells (shown in the right panel). (Left) In the
absence of MCS-R2, PcG is not cleared from the a-globin genes and thus remains present at both domains. M Gata6 represents a positive control
for PcG binding. The JMJD3 antibody used recognizes the N-terminal region of the protein (Millipore).
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We next studied humanized mice in which
MCS-R2 had been deleted to determine
whether the upstream enhancer normally
plays a role in clearing the PcG complex from
the a-globin CpG island during erythropoiesis.
As before, in the absence of MCS-R2, the
silenced z gene remains bound by PcG through-
out differentiation. However, in the absence of
MCS-R2, PRC2 is no longer cleared from the
a-globin CpG island, and JMJD3 is no longer
recruited (Fig. 3, left panel; Supplemental Fig.
8). We showed previously that PcG repression
of the a-globin gene may be mediated (at least
in part) by HDAC1, which is normally cleared
with PcG complex during erythropoiesis (Garrick
et al. 2008). Here, in the absence of MCS-R2,
HDAC1 remains bound to the a-globin genes
(Fig. 3). These contrasting observations on two
adjacent CpG islands show that MCS-R2 exerts
a specific effect on PcG clearance from the
a-globin (but not the z-globin) gene during adult
erythropoiesis.
There is increasing evidence that CpG islands,
such as those associated with the a-globin pro-
moter, constitute at least one element that can
mediate recruitment of PcG and TrxG com-
plexes to mammalian promoters (Mendenhall
et al. 2010; MD Lynch, AJ Smith, M De Gobbi,
M Flenley, JR Hughes, D Vernimmen, H Ayyub,
JA Sharpe, JA Sloane-Stanley, L Sutherland,
et al., in prep.). As previously noted, PcG-
binding sites are dynamic, are nucleosome-
depleted, and have a rapid histone turnover
(the residency time of PcG is in the order of
a fewminutes) (Ficz et al. 2005). PcG binding is
therefore thought to be dynamic and sensitive
to the antagonistic action of TrxG proteins
together with positive and negative input
from other TFs and cofactors. However, it is
not known whether the eviction of PcG si-
lencing complex from its targets, seen during
development and differentiation, depends on
the presence of distal regulatory elements or
only on (co)factors acting at proximal cis ele-
ments. In this study, we used a mouse experi-
mental model to analyze the CpG island asso-
ciated with the human a-globin promoter in
two states: without and with its interacting
distant enhancer, both in terminally differen-
tiated erythroid cells. We also compared
the recruitment of CGBP in nonexpressing versus
expressing human cells. In nonerythroid cells, the un-
methylated, nuclease-insensitive CpG island associated
with the a-globin gene is bound by PcG and is transcrip-
tionally silenced (referred to as the ‘‘silent state’’) (Fig.
4A). In erythroid cells without MCS-R2 (referred to as
‘‘basal state’’), and in contrast to nonerythroid cells
(Garrick et al. 2008), the promoter becomes accessible to
some TFs and is associated with some active chromatin
modifications (e.g., H3K4me3) with relatively low levels
of transcription (;2% of normal) (Fig. 4B). Nevertheless,
the PcG complex with its associated modification
(H3K27me3) is still prominent at the a-globin CpG
island. We also demonstrate here that PcG and CGBP
binding are mutually exclusive (cf. Figs. 2 and 3). In
erythroid cells with MCS-R2 (referred to as ‘‘active
state’’), PcG complexes are completely removed from
the CpG island (Fig. 4C). Furthermore, the histone
H3K27 demethylase JMJD3, which may remove
H3K27me3 and thereby facilitate transcription, is also
recruited at high levels. Recruitment of the SAGA
complex (e.g., PCAF and GCN5) becomes prominent
and the downstream effects (e.g., deposition of H2Bub
and H3K79 methylation) are established. At this stage,
high levels of transcription are associated with binding of
CGBP. We thus show that the recruitment of the de-
methylase JMJD3 and full clearance of the PcG-repressive
complex (including PRC2 and HDAC1) at the a-globin
CpG island depend on one or more activities mediated
by the remote regulatory element and are associated
Figure 4. Long-range control of epigenetic regulation. (A) In nonerythroid cells, the
CpG island is entirely silenced by PcG and HDAC1, associated with the repressive
histone mark H3K27me3. The promoter ‘‘P’’ is not sensitive to DNaseI, and
transcription does not occur. (B) In erythroid cells lacking the enhancer, the gene
remains repressed by PcG and marked by H3K27me3. At this basal level of
expression, the promoter becomes accessible to some TFs and chromatin-modifying
enzymes and is marked by moderate levels of H3K4me3, which reflect very low
levels of transcription. (C) In the presence of the enhancer, PcG is evicted and the
H3K27me3 histone mark is erased by recruitment of demethylase JMJD3. Acetyla-
tion (H3ac and H4ac), H3K79me3, and H2Bub increases with spreading of HAT and
Bre (SAGA) along the coding sequence ‘‘C.’’ At this activated stage, the remaining
TFs, including Pol II, are now fully recruited, and a high rate of transcription occurs.
The CpG island at this stage is also bound by CGBP.
Long-range control of epigenetic regulation
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with the transition between basal and fully activated
transcription.
These findings demonstrate for the first time that the
pattern of PcG binding at a CpG island may be affected by
cis-acting elements located far away from the associated
promoter. In contrast, the chromatin modification asso-
ciated with TrxG activity (H3K4me3) appears to be more
dependent on local changes at the CpG island that occur
in the context of basal transcription. Future studies will
address how long-range enhancers exert these effects. It is
possible that transcriptional activation per se competes
with the competitive binding of PcG complexes and is
responsible for the clearance of these complexes (MD
Lynch, AJ Smith, M De Gobbi, M Flenley, JR Hughes, D
Vernimmen, H Ayyub, JA Sharpe, JA Sloane-Stanley, L
Sutherland, et al., in prep.). The second is that upstream
elements also deliver new proteins (e.g., JMJD3) or modify
proteins (e.g., histones) that facilitate the removal of PcG.
In the past, detailed analysis of the globin genes has
established many of the general principles underlying
mammalian gene regulation, and it therefore seems
probable that this new role of distal regulatory elements
in removing PcG from their target promoters will be of
considerable general importance.
Materials and methods
Primary cells
Ter119-positive mature primary mouse erythroid cells (humanized) were
obtained by automagnetic-activated cell sorting, as previously described
(Vernimmen et al. 2007, 2009; Wallace et al. 2007). Primary human eryth-
roblasts were obtained from peripheral blood mononuclear cells (PBMCs)
collected from blood donors and expanded in a two-phase system as pre-
viously described (DeGobbi et al. 2007). Epstein-Barr virus (EBV)-transformed
lymphoblastoid cell lines were derived from healthy subjects.
Chromatin immunoprecipitation assay (ChIP)
ChIP was performed as previously described (Vernimmen et al. 2007). For
histone-modifying enzymes, chromatin was first cross-linked with EGS
(Pearce, Thermo Scientific, product no. 21565) in PBS at a final concen-
tration of 2 mM for 60 min at room temperature. Formaldehyde was then
added at a final concentration of 1% for 15 min at room temperature, and
samples were sonicated for 20 min at 4°C to fragment genomic DNA
(Bioruptor; Diagenode). The antibodies used were Pol II (H-224), JMJD3
(N-24), GCN5 (H-75), PCAF (H-369), p300 (C-20), CBP (A-22) (purchased
fromSanta Cruz Biotechnology); H3K79me1 (ab2886), H3K79me2 (ab3594),
H3K79me3 (ab2621), H3K27ac (ab4729), H3 (ab1791), CGBP (ab56035),
H3K4me3 (ab8085), and Suz12 (ab12073) (purchased from abcam); DOT1L
(A300-954A) (purchased from Bethyl Laboratory, Inc.); HDAC1 (06-720),
H3ac (06-599), H4ac (06-866), H3K9ac (07-352), H3K14ac (07-353),
H3K27me3 (07-449), H3K4me1 (07-436), H3K4me2 (07-030), H3K4me3
(05-745R), H4 (07-108), H2A (06-13923), H2B (06-1790), JMJD3 (07-1533),
and JMJD3 (07-1534) (purchased from Millipore); H2Bub (MM-0029)
(purchased fromMedimabs); and Ezh2 (PAB0649) (purchased fromAbnova).
Real-time PCR using primers and probes (59FAM–39TAMRA) for murine
and human a-globin locus were described previously (Anguita et al. 2004;
De Gobbi et al. 2007).
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